Showing results (1331-1340 of 4,366) with videos related to

Sort By:
Pageof 437
Clinical Immunology (Orlando, Fla.)|January 22, 2022
Prognostic impact of toll-like receptors gene polymorphism on outcome of COVID-19 pneumonia: A case-control studyMahmoud M Alseoudy, Mohamed Elgamal, Dalia A Abdelghany, et al.
Clinical Immunology (Orlando, Fla.)|January 22, 2022
Interleukin-7 and soluble Interleukin-7 receptor levels in type 1 diabetes - Impact of IL7RA polymorphisms, HLA risk genotypes and clinical featuresMaximilian Hoffmann, Jürgen Enczmann, Vera Balz, et al.
Clinical Immunology (Orlando, Fla.)|February 8, 2022
Erythroblastic synartesis associated with lymphoproliferative disorder: There can be more than meets the eyeCamille Mettler, Cassandre Petit, Vincent Ernest, et al.
Clinical Immunology (Orlando, Fla.)|February 12, 2022
Dysregulated protein kinase/phosphatase networks in SLE T cellsGerardo Suárez-Rojas, José C Crispín
Clinical Immunology (Orlando, Fla.)|April 1, 2022
Temporal changes in T cell subsets and expansion of cytotoxic CD4+ T cells in the lungs in severe COVID-19Naoki Kaneko, Julie Boucau, Hsiao-Hsuan Kuo, et al.
Clinical Immunology (Orlando, Fla.)|March 17, 2022
Measurement of anti-suprabasin antibodies, multiple cytokines and chemokines as potential predictive biomarkers for neuropsychiatric systemic lupus erythematosusTrang T T Hoang, Kunihiro Ichinose, Shimpei Morimoto, et al.
Clinical Immunology (Orlando, Fla.)|March 29, 2022
SLC7A5 expression is up-regulated in peripheral blood T and B lymphocytes of systemic lupus erythematosus patients, associating with renal damageJuan Tian, Xiaowei Li, Yiru Jiang, et al.
Clinical Immunology (Orlando, Fla.)|September 30, 2018
Regulation of systemic tissue injury by coagulation inhibitors in B6.MRL/lpr autoimmune miceC Moratz, R Robbins, J Eickhoff, et al.
Clinical Immunology (Orlando, Fla.)|October 6, 2018
The heterogeneity of autoimmune polyendocrine syndrome type 1: Clinical features, new mutations and cytokine autoantibodies in a Brazilian cohort from tertiary care centersFernanda Guimarães Weiler, Pärt Peterson, Beatriz Tavares Costa-Carvalho, et al.
Clinical Immunology (Orlando, Fla.)|October 9, 2018
Fra-2 is a novel candidate drug target expressed in the podocytes of lupus nephritisChangliang Xu, Yunjie Miao, Qingmeng Pi, et al.
Pageof 437